116 related articles for article (PubMed ID: 22530465)
21. American College of Radiology guidelines for breast cancer screening.
Feig SA; D'Orsi CJ; Hendrick RE; Jackson VP; Kopans DB; Monsees B; Sickles EA; Stelling CB; Zinninger M; Wilcox-Buchalla P
AJR Am J Roentgenol; 1998 Jul; 171(1):29-33. PubMed ID: 9648758
[No Abstract] [Full Text] [Related]
22. Should women 40 to 49 years of age be offered mammographic screening?
Trop I; Deck W
Can Fam Physician; 2006 Sep; 52(9):1050-2. PubMed ID: 17279208
[No Abstract] [Full Text] [Related]
23. Are mammography recommendations in women younger than 40 related to increased risk?
Kapp JM; Yankaskas BC; LeFevre ML
Breast Cancer Res Treat; 2010 Jan; 119(2):485-90. PubMed ID: 19148745
[TBL] [Abstract][Full Text] [Related]
24. [Scientific criteria methods for estimating and evaluation of screening].
Zahl PH
Tidsskr Nor Laegeforen; 2003 Feb; 123(3):333-6. PubMed ID: 12640903
[No Abstract] [Full Text] [Related]
25. Screening for breast cancer: the Swedish trial.
Tabàr L; Gad A
Radiology; 1981 Jan; 138(1):219-22. PubMed ID: 7005939
[TBL] [Abstract][Full Text] [Related]
26. Mortality reduction by breast-cancer screening.
Bonneux L
Lancet; 2003 Jul; 362(9379):245. PubMed ID: 12885491
[No Abstract] [Full Text] [Related]
27. [Assessment of mammography screening and its introduction in Germany in the Statutory Early Diagnosis Program].
von Fournier D
Zentralbl Gynakol; 1999; 121(3):159-65. PubMed ID: 10209861
[TBL] [Abstract][Full Text] [Related]
28. [Postoperative radiotherapy increases mortality in women with breast cancer diagnosed by mass screening].
Gøtzsche PC; Olsen O
Lakartidningen; 2001 Jan; 98(4):347-9. PubMed ID: 11271572
[No Abstract] [Full Text] [Related]
29. A model for determining the effect of mammography service screening.
Olsen AH; Njor SH; Vejborg I; Schwartz W; Dalgaard P; Jensen MB; Tange UB; Blichert-Toft M; Rank F; Mouridsen H; Lynge E
Acta Oncol; 2005; 44(2):120-8. PubMed ID: 15788290
[TBL] [Abstract][Full Text] [Related]
30. Declining screening mammography rates: a multigenerational loss of opportunity?
Carlos RC
AJR Am J Roentgenol; 2009 Feb; 192(2):388-9. PubMed ID: 19155399
[No Abstract] [Full Text] [Related]
31. Nationwide mammography screening registers: the best way to go for mortality evaluation - but there is no free lunch.
Skaane P
Acta Radiol; 2011 Apr; 52(3):235. PubMed ID: 21498355
[No Abstract] [Full Text] [Related]
32. Breast cancer screening with mammography.
Elwood JM; Cox B; Richardson AK
Lancet; 1993 Jun; 341(8859):1531; author reply 1531-2. PubMed ID: 8099397
[No Abstract] [Full Text] [Related]
33. Breast cancer screening with mammography.
Hakama M
Lancet; 1993 Jun; 341(8859):1531; author reply 1531-2. PubMed ID: 8099398
[No Abstract] [Full Text] [Related]
34. The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States.
Schootman M; Jeffe D; Reschke A; Aft R
Breast Cancer Res Treat; 2004 Jun; 85(3):219-22. PubMed ID: 15111759
[TBL] [Abstract][Full Text] [Related]
35. Mammography: a critical evaluation of its role in breast cancer screening, especially in developing countries.
Miller AB
J Public Health Policy; 1989; 10(4):486-98. PubMed ID: 2621252
[TBL] [Abstract][Full Text] [Related]
36. Screening mammography re-evaluated.
Nyström L
Lancet; 2000 Feb; 355(9205):748-9; author reply 752. PubMed ID: 10703821
[No Abstract] [Full Text] [Related]
37. Screening mammography in Minnesota cancer patients.
Pagidipala S; Bushhouse S
Cancer Detect Prev; 2005; 29(2):116-23. PubMed ID: 15829371
[TBL] [Abstract][Full Text] [Related]
38. [Mammography screening for all women 50 to 69 years old. Increases longevity--or only duration of suffering? Pro (interview by Waldtraud Paukstadt)].
Schreer I
MMW Fortschr Med; 2007 Feb; 149(8):6-7. PubMed ID: 17615690
[No Abstract] [Full Text] [Related]
39. Decreased mammography utilization in the United States: why and how can we reverse the trend?
Wolf AB; Brem RF
AJR Am J Roentgenol; 2009 Feb; 192(2):400-2. PubMed ID: 19155401
[TBL] [Abstract][Full Text] [Related]
40. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
